glp 1 agonist cardiovascular outcomes The effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action Cardiovascular Effects and Tolerability of
Description
This comprehensive review critically evaluates recent advances in BBRs anti-obesity pharmacology through three lenses: (1) preclinical and clinical evidence from randomized controlled trials, (2) molecular mechanisms underlying metabolic regulation, and (3) innovative strategies for pharmacokinetic optimization
This comprehensive review explores the mechanisms, clinical implications, and mitigation strategies, including exercise, protein intake, and adjunct therapies.
How do they work
Supports a healthy metabolism
